Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000971287 | SCV001118924 | benign | not provided | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000971287 | SCV001983350 | likely benign | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002434329 | SCV002752782 | likely benign | Cardiovascular phenotype | 2019-04-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000971287 | SCV004010806 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | GPIHBP1: BP4, BP7 |
Breakthrough Genomics, |
RCV000971287 | SCV005222255 | likely benign | not provided | criteria provided, single submitter | not provided |